These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30604333)

  • 1. Lipid Nanoemulsions of Rebamipide: Formulation, Characterization, and In Vivo Evaluation of Pharmacokinetic and Pharmacodynamic Effects.
    Narala A; Guda S; Veerabrahma K
    AAPS PharmSciTech; 2019 Jan; 20(1):26. PubMed ID: 30604333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and pharmacodynamic studies of iloperidone-loaded lipid nanoemulsions via oral route of administration.
    Narala A; Suram D; Veerabrahma K
    Drug Dev Ind Pharm; 2021 Apr; 47(4):618-625. PubMed ID: 33784221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and in vitro cytotoxic evaluation of parenteral docetaxel lipid nanoemulsions for application in cancer treatment.
    Venkateshwarlu I; Prabhakar K; Ali M; Kishan V
    PDA J Pharm Sci Technol; 2010; 64(3):233-41. PubMed ID: 21502023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of Gastric Mucosal Injury Model Animals of Rebamipide Formulation--Study of Therapeutic Equivalence].
    Abe N; Funato H; Hirata A; Nakai M; Iizuka M; Shiraishi H; Jobu K; Yagi Y; Kadota A; Ogi K; Yokota J; Miyamura M
    Yakugaku Zasshi; 2016; 136(4):677-84. PubMed ID: 27040349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral absorption and pharmacokinetics of rebamipide and rebamipide lysinate in rats.
    Shin BS; Kim CH; Jun YS; Yoon CH; Rho JI; Lee KC; Han HS; Yoo SD
    Drug Dev Ind Pharm; 2004 Sep; 30(8):869-76. PubMed ID: 15521332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
    Dudhipala N; Veerabrahma K
    Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and pharmacodynamic studies of nisoldipine-loaded solid lipid nanoparticles developed by central composite design.
    Dudhipala N; Veerabrahma K
    Drug Dev Ind Pharm; 2015; 41(12):1968-77. PubMed ID: 25830370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local gastric and serum concentrations of rebamipide following oral administration to patients with chronic gastritis.
    Naito Y; Yoshikawa T; Iinuma S; Miyazaki R; Yagi N; Yoshida N; Osumi T; Hirao Y; Kondo M
    Arzneimittelforschung; 1996 Jul; 46(7):698-700. PubMed ID: 8842341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation of solid dispersion of rebamipide evaluated in a rat model for improved bioavailability and efficacy.
    Tung NT; Park CW; Oh TO; Kim JY; Ha JM; Rhee YS; Park ES
    J Pharm Pharmacol; 2011 Dec; 63(12):1539-47. PubMed ID: 22060284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local gastric and serum concentrations of rebamipide following oral ingestion in healthy volunteers.
    Akamatsu T; Nakamura N; Furuya N; Shimizu T; Gotou A; Kiyosawa K; Katsuyama T; Osumi T; Hirao Y; Miyamoto G
    Dig Dis Sci; 2002 Jun; 47(6):1399-404. PubMed ID: 12064818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and bioequivalence of two formulations of rebamipide 100-mg tablets: a randomized, single-dose, two-period, two-sequence crossover study in healthy Korean male volunteers.
    Cho HY; Yoon H; Park GK; Lee YB
    Clin Ther; 2009 Nov; 31(11):2712-21. PubMed ID: 20110013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Permeabilities of rebamipide via rat intestinal membranes and its colon specific delivery using chitosan capsule as a carrier.
    Huang BB; Li GF; Luo JH; Duan L; Nobuaki K; Akira Y
    World J Gastroenterol; 2008 Aug; 14(31):4928-37. PubMed ID: 18756602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicochemical, pharmacokinetic and pharmacodynamic evaluations of novel ternary solid dispersion of rebamipide with poloxamer 407.
    Park CW; Tung NT; Rhee YS; Kim JY; Oh TO; Ha JM; Chi SC; Park ES
    Drug Dev Ind Pharm; 2013 Jun; 39(6):836-44. PubMed ID: 22510064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved anti-hyperlipidemic activity of Rosuvastatin Calcium via lipid nanoparticles: Pharmacokinetic and pharmacodynamic evaluation.
    Dudhipala N; Veerabrahma K
    Eur J Pharm Biopharm; 2017 Jan; 110():47-57. PubMed ID: 27810472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parenteral nanoemulsions as promising carriers for brain delivery of risperidone: Design, characterization and in vivo pharmacokinetic evaluation.
    Đorđević SM; Cekić ND; Savić MM; Isailović TM; Ranđelović DV; Marković BD; Savić SR; Timić Stamenić T; Daniels R; Savić SD
    Int J Pharm; 2015 Sep; 493(1-2):40-54. PubMed ID: 26209070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiulcer mechanism of action of rebamipide, a novel antiulcer compound, on diethyldithiocarbamate-induced antral gastric ulcers in rats.
    Ogino K; Hobara T; Ishiyama H; Yamasaki K; Kobayashi H; Izumi Y; Oka S
    Eur J Pharmacol; 1992 Feb; 212(1):9-13. PubMed ID: 1313372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic effect of rebamipide against the irritative and healing impairment actions of alendronate in rat stomachs.
    Aihara E; Hayashi S; Amagase K; Kato S; Takeuchi K
    Inflammopharmacology; 2007 Oct; 15(5):196-202. PubMed ID: 17943251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rebamipide reduces recurrence of experimental gastric ulcers: role of free radicals and neutrophils.
    Sakurai K; Osaka T; Yamasaki K
    Dig Dis Sci; 2005 Oct; 50 Suppl 1():S90-6. PubMed ID: 16184427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A potent preparation method combining neutralization with microfluidization for rebamipide nanosuspensions and its in vivo evaluation.
    Shi Y; Zou M; An Y; Ji Z; Gao P; Cheng G
    Drug Dev Ind Pharm; 2013 Jul; 39(7):996-1004. PubMed ID: 22624728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Domperidone Solid Lipid Nanoparticles: In Vitro and In Vivo Characterization.
    Shazly GA; Alshehri S; Ibrahim MA; Tawfeek HM; Razik JA; Hassan YA; Shakeel F
    AAPS PharmSciTech; 2018 May; 19(4):1712-1719. PubMed ID: 29532427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.